{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/syphilis/management/management-of-suspected-syphilis/","result":{"pageContext":{"chapter":{"id":"4f71ffc0-f98f-5f3f-9752-9b49ae232b3f","slug":"management-of-suspected-syphilis","fullItemName":"Scenario: Management of suspected syphilis","depth":2,"htmlHeader":"<!-- begin field 37ff1394-0f7a-4b9c-b973-fe6114e523c1 --><h2>Scenario: Management of suspected syphilis</h2><!-- end field 37ff1394-0f7a-4b9c-b973-fe6114e523c1 -->","summary":"Covers the primary care management of people with suspected syphilis. It emphasizes the importance of referral but gives advice on testing in primary care if the person refuses referral.","htmlStringContent":"<!-- begin item 24284d53-2984-4175-80c1-e15a408e423e --><!-- begin field 07826a58-2fe9-4020-a5e4-acd900ae2c23 --><p>From age 16 years onwards.</p><!-- end field 07826a58-2fe9-4020-a5e4-acd900ae2c23 --><!-- end item 24284d53-2984-4175-80c1-e15a408e423e -->","topic":{"id":"e20bf9b2-b7e3-5fd7-8829-79eff4ba17c6","topicId":"acdacd5c-088e-4bc3-b3f7-ec4a5cdf69d3","topicName":"Syphilis","slug":"syphilis","lastRevised":"Last revised in December 2019","chapters":[{"id":"e937b36a-5802-56e1-8c33-d31a18aa8993","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"8e1009a7-fe76-55c5-a3b4-71f4ab22bd6e","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"3744efb5-ed9a-556d-b9ca-9497279f7760","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"1a6d6164-e61e-5a2b-899c-b42fdd49c070","slug":"changes","fullItemName":"Changes"},{"id":"42b3bae7-13c9-5f24-8610-e6373d51db6c","slug":"update","fullItemName":"Update"}]},{"id":"783939a0-7dd0-51dc-b0f1-1a79adaeeca2","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"481c647b-0185-5ec1-944f-ea3f095a698e","slug":"goals","fullItemName":"Goals"},{"id":"5d1c604c-5520-5fd3-906b-277d5bc648e4","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"c1d0b67c-29a5-571e-a1e8-8037aa0cca4c","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"7c0ed1af-9d86-5a85-a39d-bac1f3ee5aa6","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"b5682ffb-43d2-5180-b6ef-2442bbeddb7f","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"46feecc4-1ab5-56cc-88d4-0a134227de45","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"4bd10070-ee64-5280-b905-06b3eb114be4","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"d6720e54-e02c-58ce-b1a6-033c00e802a7","slug":"definition","fullItemName":"Definition"},{"id":"a0c2113e-ec1b-5779-a10a-478a338f5123","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"6dd4a0d4-fa9a-593e-888e-9e2f53fd28f7","slug":"prevalence","fullItemName":"Prevalence"},{"id":"b748bc0a-b4dd-5cd5-a38c-5a8565c1a29a","slug":"prognosis","fullItemName":"Prognosis"},{"id":"76255843-9dc0-5005-8f9d-8ad229263649","slug":"complications","fullItemName":"Complications"}]},{"id":"f6319d5a-f16e-52a4-85ba-52fc5bdf0dfd","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"bc588915-36d7-5368-b3b1-55539fe07a98","slug":"when-to-suspect-syphilis","fullItemName":"When to suspect syphilis"},{"id":"6c61a9cf-feda-52ea-b119-caf357efc7b1","slug":"assessment","fullItemName":"Assessment"},{"id":"ca12c8de-69c5-5487-9003-b91829ef1e03","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"eb1d937a-afbb-5c69-807a-d6560cf1f127","fullItemName":"Management","slug":"management","subChapters":[{"id":"4f71ffc0-f98f-5f3f-9752-9b49ae232b3f","slug":"management-of-suspected-syphilis","fullItemName":"Scenario: Management of suspected syphilis"}]},{"id":"94de066c-68d9-5f6d-93f5-8e51c88d0606","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"ec180069-3dfc-52bb-8d33-474b29350978","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"5989431d-2289-5a0d-8965-3fb04b1df99d","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"9a2ece67-c769-5551-bfb8-806b9499e079","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"daa5da38-6a12-51e2-88c0-c16841f9c9d8","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"18097171-0d2a-50aa-bf36-707fb65c028c","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"1ec2e8ce-2b99-5671-b5e5-14986c70f439","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"0656a654-b988-57ed-b218-fb52feabfa93","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"eb1d937a-afbb-5c69-807a-d6560cf1f127","slug":"management","fullItemName":"Management"},"subChapters":[{"id":"b3f733fc-3102-558f-beac-dd5667939049","slug":"primary-care-management","fullItemName":"Primary care management","depth":3,"htmlHeader":"<!-- begin field 52364d5b-a01b-46bb-a807-76a4898809ab --><h3>How should I manage a person with suspected syphilis in primary care?</h3><!-- end field 52364d5b-a01b-46bb-a807-76a4898809ab -->","summary":null,"htmlStringContent":"<!-- begin item e13f0445-af6b-4948-a4be-7db88a9263db --><!-- begin field be7d030f-afcf-4318-85bc-8be87c09b55b --><ul><li><strong>Refer all people with suspected syphilis to a genito-urinary medicine (GUM) clinic or other specialist local sexual health service</strong><strong>. </strong>Referral to a specialist service is required because:<ul><li>Some tests for syphilis may not be available in primary care.</li><li>Interpretation of test results is difficult — specialist expertise is needed to confirm diagnosis; distinguish between current and past infection; determine stage of disease; and monitor treatment success.</li><li>Currently recommended first-line treatments for syphilis (including parenteral benzathine and procaine penicillin) are unlicensed in the UK and not readily available for use in primary care.</li><li>Full screening for other sexually transmitted infections (including HIV) should be carried out in addition to syphilis.</li><li>Contact tracing is needed to help limit ongoing transmission, prevent re-infection and ensure that contacts receive prompt treatment when appropriate — partner notification should be carried out by specially trained staff.</li><li>Specialist follow-up is needed to detect possible re-infection and relapse — cerebrospinal fluid examination and re-treatment may be indicated.</li></ul></li><li><strong>Explain the condition, risk factors, and potential complications; discuss prevention. </strong><ul><li>Patient information is available from:<ul><li>The Family Planning Association (FPA) \"<a href=\"http://www.fpa.org.uk/sites/default/files/syphilis-information-and-advice.pdf\" target=\"_blank\" rel=\"noopener\" data-hyperlink-id=\"bf4accd1-3c4e-4127-97bc-ab3000f90381\">Syphilis</a>.\"</li><li>The British Association for Sexual Health and HIV (BASHH) \"<a href=\"http://www.bashhguidelines.org/media/1037/sts_pil_non-pregnant_digital_2016.pdf\" target=\"_blank\" rel=\"noopener\" data-hyperlink-id=\"48366e1c-e1b2-4178-9fca-ab3000f90398\">A guide to syphilis.</a>\"    </li><li>The NHS \"<a href=\"http://www.nhs.uk/conditions/syphilis/\" target=\"_blank\" rel=\"noopener\" data-hyperlink-id=\"f90a51dd-a954-4fce-9ca2-ab3000f903a6\">Syphilis.</a>\"</li></ul></li><li>Preventative measures include:<ul><li>Increased use of condoms.</li><li>Avoidance of drugs and alcohol when having sex.</li><li>Risk-reduction counselling and regular syphilis screening for <a class=\"topic-reference internal-reference\" href=\"/topics/syphilis/background-information/risk-factors/\">people at high risk</a> — available through GUM.</li><li>Early recognition of the clinical features of syphilis, prompt treatment and prophylactic treatment of exposed contacts.</li></ul></li></ul></li><li><strong>Advise the person to avoid all sexual contact and exposure of other people to active lesions until</strong><strong>:</strong><ul><li>The diagnosis is excluded, <em>or</em></li><li>Successful treatment of the condition has been confirmed.</li></ul></li><li><strong>For people who are HIV positive who decline referral to a GUM clinic</strong>:<ul><li>Offer referral to an infectious diseases clinic or HIV centre if they are routinely reviewed there for HIV monitoring.</li></ul></li><li><strong>For people who decline referral to a GUM clinic (or an infectious diseases clinic, or HIV centre for those with HIV infection):</strong><ul><li>Discuss with a GUM specialist. If testing in primary care is recommended this may include <a class=\"topic-reference internal-reference\" href=\"/topics/syphilis/management/management-of-suspected-syphilis/#serology-testing-for-syphilis\">swabs</a> from active lesions and <a class=\"topic-reference internal-reference\" href=\"/topics/syphilis/management/management-of-suspected-syphilis/#serology-testing-for-syphilis\">serology</a>: <ul><li>If all tests are negative, repeat serological testing is required to confirm absence of infection – timing of this is dependent on suspected date of exposure and clinical features. Discuss with a GUM specialist.</li><li>If any of the tests are positive, strongly recommend referral to a GUM clinic for further specialist assessment, management and follow up — appropriate treatment in primary care is not easily accessible, specialist input is required.</li></ul></li><li>Discuss screening for other sexually transmitted infections, including chlamydia, gonorrhoea, Hepatitis B, Hepatitis C, and HIV.<ul><li>For further information, see the CKS topics on: <a class=\"topic-reference external-reference\" href=\"/topics/chlamydia-uncomplicated-genital/\">Chlamydia - uncomplicated genital</a>,  <a class=\"topic-reference external-reference\" href=\"/topics/gonorrhoea/\">Gonorrhoea</a>, <a class=\"topic-reference external-reference\" href=\"/topics/hepatitis-b/\">Hepatitis B</a>, <a class=\"topic-reference external-reference\" href=\"/topics/hepatitis-c/\">Hepatitis C</a>, and <a class=\"topic-reference external-reference\" href=\"/topics/hiv-infection-aids/\">HIV infection and AIDS</a>. </li><li>Take a virology swab from any active lesions (genital and extragenital, including oral lesions) if present, to exclude herpes simplex.</li></ul></li></ul></li><li><strong>Advise people with suspected syphilis who decline testing, and people diagnosed with syphilis who decline treatment,</strong> that if they are found to have infected other people with syphilis via unprotected sexual contact or non-sexual contact with active lesions, despite knowing that this could occur, they may be subject to prosecution.</li></ul><!-- end field be7d030f-afcf-4318-85bc-8be87c09b55b --><!-- end item e13f0445-af6b-4948-a4be-7db88a9263db -->","subChapters":[{"id":"dddf762f-aad2-5691-a07b-0c497cb126b9","slug":"serology-testing-for-syphilis","fullItemName":"Serology testing for syphilis","depth":4,"htmlHeader":"<!-- begin field 72af89cb-df2e-4110-9700-d688192da98b --><h4>Laboratory diagnosis</h4><!-- end field 72af89cb-df2e-4110-9700-d688192da98b -->","summary":null,"htmlStringContent":"<!-- begin item 1c859f99-40c1-4ef3-9fe7-43090770c7ab --><!-- begin field 9f14fab8-6380-4a5a-a0bc-a5b08b1033cd --><p><strong>Specific tests included in a full syphilis screen may vary locally, but usually include a combination of treponemal and non-treponemal tests which should be interpreted in the context of clinical and geographical background.</strong></p><ul><li><strong>Direct tests for syphilis</strong> are used to demonstrate <em>T. pallidum</em> from swabs taken of primary lesions and include:<ul><li><strong>Dark-field microscopy</strong> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">CDC, 2015a</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">WHO, 2016</a>]:<ul><li>Requires specialist equipment and training.</li><li>Has a high specificity but low sensitivity (less than 50%) — a negative result does not exclude syphilis.</li><li>Is not suitable for oral lesions due to presence of commensal treponemes.</li></ul></li><li><strong>Polymerase chain reaction (PCR)</strong> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">Kingston, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">WHO, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">BASHH, 2019</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">ECDC, 2019</a>]. <ul><li>Is available at reference laboratories.</li><li>Can be used for oral or other lesions where commensal treponemes may be present.</li></ul></li></ul></li><li><strong>Serological tests for syphilis include:</strong><ul><li><strong>Specific or treponemal tests</strong> such as treponemal enzyme immunoassay (EIA), or treponemal chemiluminescent assay (CLIA); Treponema pallidum haemagglutination assay (TPHA); Treponema pallidum particle agglutination assay (TPPA), ﬂuorescent treponemal antibody absorption test (FTA-abs), and Treponema pallidum immunoblot [<a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">CDC, 2015a</a>]  [<a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">Kingston, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">PHE, 2016</a>]  [<a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">WHO, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">BASHH, 2019</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">ECDC, 2019</a>]. <ul><li>Most treponemal tests detect treponemal IgG and IgM — they cannot diﬀerentiate syphilis from non-venereal treponemal infections (for example yaws [<em>T. pallidum pertenue</em>], endemic syphilis [<em>T. pallidum endemicum</em>] and pinta [<em>T. pallidum subspecies carateum</em>]) which are endemic in some tropical countries.</li><li>The sensitivity of treponemal tests is variable in early primary syphilis and high in secondary, early latent and late latent stages.</li><li>Treponemal tests are not useful for monitoring effectiveness of treatment or disease activity as in most people they remain positive for life regardless of treatment.</li><li>The British Association for Sexual Health and HIV (BASHH) recommend EIA/CLIA as the screening test of choice for syphilis.</li></ul></li><li><strong>Non-specific or non-treponemal tests</strong> (such as Venereal Diseases Research Laboratory (VDRL) carbon antigen test/RPR test) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">CDC, 2015a</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">WHO, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">BASHH, 2019</a>]  [<a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">ECDC, 2019</a>]: <ul><li>Have low sensitivity in early primary syphilis, high sensitivity in secondary and early latent stages and low sensitivity in late stage syphilis.</li><li>Without treatment titres peak after 1–2 years and remain positive at low levels in late stage disease.</li><li>Following treatment titres usually decline and can be used to monitor effectiveness of treatment.</li></ul></li></ul></li><li><strong>False negative serology </strong>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">Kingston, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">BASHH, 2019</a>]<ul><li>Treponemal screening tests are negative before a chancre develops and remain negative for up to two weeks afterwards.</li><li>A false-negative RPR/VDRL test may occur in secondary or early latent syphilis — this may be more likely to occur in people co-infected with HIV.</li><li>The RPR/VDRL and IgM may be negative in late syphilis.</li></ul></li><li><strong>False positive serology </strong>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">CDC, 2015a</a>]  [<a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">Kingston, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">New Zealand Sexual Health Society, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">BASHH, 2019</a>]. <ul><li>False-positive results occur occasionally with any of the serological tests for syphilis.</li><li>Some conditions and other factors such as viral infections, malignancy, autoimmune disorders, older age, injecting drug use and pregnancy are associated with increased likelihood of a false positive non-treponemal test.</li></ul></li><li><strong>Repeat testing </strong>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">Kingston, 2016</a>]<ul><li>All positive screening tests must be confirmed with a different serological test.</li><li>Negative serology tests should be repeated at 6 and 12 weeks after an isolated high risk exposure or 2 weeks after possible chancres that are dark-field microscopy and/or PCR negative.</li></ul></li><li><strong>Examination of cerebrospinal fluid (in addition to serology) </strong>is required for diagnosis of neurosyphilis or ocular syphilis [<a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">IUSTI, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">CDC, 2015a</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">PHE, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">WHO, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">BASHH, 2019</a>]. </li></ul><!-- end field 9f14fab8-6380-4a5a-a0bc-a5b08b1033cd --><!-- end item 1c859f99-40c1-4ef3-9fe7-43090770c7ab -->","subChapters":[]},{"id":"c7b727de-785f-5309-8769-41d50cdfdb22","slug":"basis-for-recommendation-d65","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field df54e66b-52f4-4173-86d5-7f8f5a7281e9 --><h4>Basis for recommendation</h4><!-- end field df54e66b-52f4-4173-86d5-7f8f5a7281e9 -->","summary":null,"htmlStringContent":"<!-- begin item d65586e2-2649-4e6b-9645-15f45eb3ac9e --><!-- begin field 9cab4301-3967-4c5a-8474-58c52ddebb42 --><p>The recommendations on the management of syphilis are based on clinical guidelines <em>Sexually transmitted infections in primary care</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">Lazaro, 2013</a>], <em>European guideline on the management of syphilis</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">IUSTI, 2014</a>], <em>Sexually transmitted diseases treatment guidelines</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">CDC, 2015a</a>], <em>UK national guidelines on the management of syphilis 2015</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">Kingston, 2016</a>], <em>WHO guidelines for the treatment of Treponema pallidum (syphilis)</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">WHO, 2016</a>], <em>Syphilis. Management summary</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">New Zealand Sexual Health Society, 2017</a>], and <em>UK national guidelines on the management of syphilis</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">BASHH, 2019</a>], the reports <em>Syphilis and congenital syphilis in Europe. A review of epidemiological trends (2007-2018) and options for response</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">ECDC, 2019</a>] and <em>Addressing the increase in syphilis in England: PHE Action Plan</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">PHE, 2019</a>], and expert opinion in review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">Stoltey, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">Nyatsanza, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">New York City Department of Health and New York City STD Prevention Training Center, 2019</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">O&rsquo;Byrne, 2019</a>].</p><h5>Referral to genito-urinary medicine (GUM)</h5><ul><li>Clinical guidance [<a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">Lazaro, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">Kingston, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">New Zealand Sexual Health Society, 2017</a>] highly recommends that all people with suspected syphilis are referred to a GUM clinic.<ul><li>Interpretation of tests is difficult — specialist input is required to confirm diagnosis, distinguish between current and past infection, determine the stage of the disease and assess response to treatment.<ul><li>It is important to establish the stage of the disease because this influences the type and duration of treatment recommended [<a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">Kingston, 2016</a>]. </li><li>Assessing serologic response to treatment is difficult — definitive criteria for cure or failure are not well established [<a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">CDC, 2015a</a>].</li><li>Public Health England recommends follow up testing at 3, 6, 9 and 12 months. Following adequate treatment of primary, secondary and early latent syphilis RPR titre should decline at least fourfold by 6 months. Further follow up may be necessary at 6-monthly intervals until RPR negative or serofast. Around 15% of people without HIV and a higher proportion of people with HIV will not meet these criteria [<a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">PHE, 2016</a>]. </li></ul></li><li>The first-line treatment, intramuscular benzathine benzylpenicillin (off-label), is not readily available in primary care.<ul><li>The treatment of choice is a parenteral, rather than oral, penicillin (off-label) as therapy is supervised and bioavailability guaranteed [<a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">Kingston, 2016</a>].</li><li>There is currently no licensed benzathine benzylpenicillin available in the UK — all stock has to be imported (March 2018) <a href=\"http:// https//www.sps.nhs.uk/medicines/benzathine-benzylpenicillin/\" target=\"_blank\" rel=\"noopener\" data-hyperlink-id=\"c28f33ff-15e3-4b61-ae00-ab300102101e\">NHS Specialist Pharmacy Service.</a></li></ul></li><li>Contact tracing — all people with confirmed syphilis infection should have partner notification discussed at diagnosis [<a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">Kingston, 2016</a>].<ul><li>Partner notification may be difficult and the look back period depends on the stage of infection — in the case of a person with late latent or tertiary syphilis, this could involve the person's entire sexual lifetime. GUM clinics have the necessary dedicated and specially trained staff to manage this [<a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">McClean, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">Tiplica, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">Kingston, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">PHE, 2019</a>].</li><li>Epidemiologic treatment should be oﬀered for asymptomatic contacts in the window period [<a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">Kingston, 2016</a>].</li></ul></li><li>Specialist follow-up is needed to detect possible re-infection and relapse [<a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">Kingston, 2016</a>].<ul><li>The recommended minimal clinical and serological follow-up for syphilis is at 3, 6 and 12 months, then if indicated, six-monthly until serologically negative or serofast.</li><li>Cerebrospinal fluid (CSF) examination and re-treatment may be indicated.</li></ul></li></ul></li></ul><h5>Patient information on syphilis</h5><ul><li>UK clinical guidance on syphilis [<a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">Kingston, 2016</a>] recommends explanation of the condition and discussion on long term health implications for the person and their partners/families.</li><li>The listed preventative measures can lower syphilis transmission rates [<a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">Stoltey, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">New York City Department of Health and New York City STD Prevention Training Center, 2019</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">PHE, 2019</a>]. <ul><li>Simple sexual health promotion messages (to improve awareness and knowledge of syphilis and increase condom use) and access to testing and treatment services are the mainstay of STI prevention in the general population.</li><li>More targeted messages and interventions (for example regular screening and risk reduction counselling) are needed for high risk groups [<a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">PHE, 2019</a>].</li><li>From November 2019 onwards, Public Health England will be including syphilis testing within its National HIV self-sampling service, which is available through an online portal [<a href=\"http://www.freetesting.hiv/\" target=\"_blank\" rel=\"noopener\" data-hyperlink-id=\"9316cc1c-8505-48f6-90ab-ab300102101e\">www.freetesting.hiv</a>] for people at higher risk of HIV infection.</li></ul></li></ul><h5>Advice on avoidance of sexual contact</h5><ul><li>Several clinical guidelines recommend sexual abstinence to help prevent potential onward transmission of syphilis to others [<a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">Kingston, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">Nyatsanza, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">New Zealand Sexual Health Society, 2017</a>].</li><li>There is very little evidence on the length of time sexual abstinence is recommended following treatment — UK guidance [<a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">Kingston, 2016</a>] recommends that sexual contact of any kind should be avoided until the lesions of early syphilis (if they were present) are fully healed and for two weeks following completion of treatment.</li></ul><h5>Referral to an infectious disease clinic or HIV centre for people who decline referral to a GUM clinic</h5><ul><li>Testing and treatment for people with and without HIV co-infection is the same. People with HIV co-infection may be at higher risk of treatment failure compared those without HIV. This risk is thought to be very small — careful serologic follow-up is recommended, especially if non-penicillin regimes are used [<a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">Kingston, 2016</a>].</li></ul><h5>Syphilis testing in primary care</h5><ul><li>Expert opinion in the Royal College of General Practitioners and BASHH guideline <em>Sexually transmitted infections in primary care</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">Lazaro, 2013</a>] recommends testing for syphilis in primary care for people who do not consent to referral.<ul><li>In the opinion of one CKS expert reviewer, although specialist expertise is required to interpret any positive test results, this may still effectively be done by seeking specialist advice when the results become available [<a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">Chauhan, Personal Communication, 2014</a>].</li></ul></li><li>A full syphilis screen may not be readily available in primary care; therefore, CKS recommends that, in some instances, the laboratory will need to be contacted to arrange this.<ul><li>Syphilis polymerase chain reaction (PCR) testing on swabs may not be readily available.</li></ul></li><li>One expert reviewer recommends that if active lesions are present testing for herpes simplex should also be carried out as this is the most common differential diagnosis for an ulcer [<a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">Chauhan, Personal Communication, 2014</a>].</li></ul><h5>Offering a full STI screen</h5><ul><li>Expert opinion in clinical guidelines [<a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">Lazaro, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">IUSTI, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">CDC, 2015a</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">Kingston, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">PHE, 2019</a>] and review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">Nyatsanza, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">BMJ Best Practice, 2019</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">O&rsquo;Byrne, 2019</a>] is that full sexual health screening (including HIV testing) should be recommended in addition to syphilis testing as people at risk of syphilis are also at risk of other STIs.</li></ul><h5>Managing test results in primary care</h5><ul><li>Expert opinion in clinical guidelines and from a CKS reviewer, is that interpretation of serology test results requires specialist expertise to make the diagnosis, distinguish between current and past infection, determine stage of the disease and appropriate treatment [<a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">Chauhan, Personal Communication, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">CDC, 2015a</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">Kingston, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">New Zealand Sexual Health Society, 2017</a>].</li><li>The recommendation on repeat testing, if the initial result is negative, is based on the clinical guideline <em>UK National Guidelines on management of syphilis</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">Kingston, 2016</a>].</li></ul><h5>Advice for people who decline testing or treatment</h5><ul><li>This information is based on guidance from the Crown Prosecution Service: Intention or reckless sexual transmission of infection Section 18 or 20 of the Offences against the person act [<a class=\"bibliography-reference internal-reference\" href=\"/topics/syphilis/references/\">Crown Prosecution Service, 2014</a>].</li></ul><!-- end field 9cab4301-3967-4c5a-8474-58c52ddebb42 --><!-- end item d65586e2-2649-4e6b-9645-15f45eb3ac9e -->","subChapters":[]}]}]}}},"staticQueryHashes":["3666801979"]}